Shattuck Labs (STTK) Income from Continuing Operations (2019 - 2026)

Shattuck Labs' (STTK) quarterly Income from Continuing Operations came in at 14766000.0 in Q1 2026, down 7.78% year-on-year from 16011888.55 in Q1 2025, and up 87.7% on a QoQ basis from 120057000.0 in Q4 2025.

Shattuck Labs (STTK) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has 8 years of Income from Continuing Operations data on file, last reported at 14766000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 7.78% year-over-year to 14766000.0 in Q1 2026; TTM through Mar 2026 was 159071000.0, a 7.49% increase from a year earlier, with the FY2025 full-year figure at 155491000.0, up 9.08% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 14766000.0, up from 120057000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for STTK reached as high as 11116000.0 in Q3 2025 and fell as low as 120057000.0 in Q4 2025.
  • Historically, Income from Continuing Operations has averaged 38259235.29 across 5 years, with a median of 26076000.0 in 2022.
  • Across the five-year window, Income from Continuing Operations tumbled 265.61% in 2023 and soared 57.77% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 26076000.0 in 2022, then tumbled by 265.61% to 95337000.0 in 2023, then fell by 20.9% to 115263000.0 in 2024, then retreated by 4.16% to 120057000.0 in 2025, then surged by 87.7% to 14766000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 14766000.0 in Q1 2026, 120057000.0 in Q4 2025, and 11116000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -37.09 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Shattuck Labs 831.66 Mn 831.66 Mn - -14.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.77 Mn
Dec 31, 2025 -120.06 Mn
Sep 30, 2025 -11.12 Mn
Jun 30, 2025 -13.13 Mn
Mar 31, 2025 -13.70 Mn
Dec 31, 2024 -115.26 Mn
Sep 30, 2024 -18.72 Mn
Jun 30, 2024 -24.26 Mn
Mar 31, 2024 -32.44 Mn
Dec 31, 2023 -95.34 Mn
Sep 30, 2023 -28.70 Mn
Jun 30, 2023 -23.05 Mn
Mar 31, 2023 -21.86 Mn
Dec 31, 2022 -26.08 Mn
Sep 30, 2022 -31.67 Mn
Jun 30, 2022 -29.15 Mn
Mar 31, 2022 -31.11 Mn
Dec 31, 2021 -22.41 Mn
Sep 30, 2021 -36.63 Mn
Jun 30, 2021 -49.51 Mn